Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab

Saved in:
Bibliographic Details
Main Authors: Efterpi Zafiriou, Emmanouil Karampinis, Vasileios Papadopoulos, Georgia Stefani, Athanasios Kotsakis, George Vassilopoulos
Format: Article
Language:English
Published: Mattioli1885 2025-01-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/4642
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540729904201728
author Efterpi Zafiriou
Emmanouil Karampinis
Vasileios Papadopoulos
Georgia Stefani
Athanasios Kotsakis
George Vassilopoulos
author_facet Efterpi Zafiriou
Emmanouil Karampinis
Vasileios Papadopoulos
Georgia Stefani
Athanasios Kotsakis
George Vassilopoulos
author_sort Efterpi Zafiriou
collection DOAJ
format Article
id doaj-art-bc912dd21ae24f5cad9b7a425e5a99bc
institution Kabale University
issn 2160-9381
language English
publishDate 2025-01-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-bc912dd21ae24f5cad9b7a425e5a99bc2025-02-04T15:41:40ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4642Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/CemiplimabEfterpi Zafiriou0Emmanouil Karampinis1Vasileios Papadopoulos2Georgia Stefani3Athanasios Kotsakis4George Vassilopoulos5Department of Dermatology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, GreeceDepartment of Dermatology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, GreeceDepartment of Oncology, University General Hospital of Larissa, Larissa, GreeceDepartment of Hematology, UHL, University of Thessaly Medical School, Larissa, GreeceDepartment of Oncology, University General Hospital of Larissa, Larissa, GreeceDepartment of Hematology, UHL, University of Thessaly Medical School, Larissa, Greecehttps://dpcj.org/index.php/dpc/article/view/4642cutaneous squamous cell carcinomaRuxolitinibanti-PD-1interferon alpha2b
spellingShingle Efterpi Zafiriou
Emmanouil Karampinis
Vasileios Papadopoulos
Georgia Stefani
Athanasios Kotsakis
George Vassilopoulos
Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
Dermatology Practical & Conceptual
cutaneous squamous cell carcinoma
Ruxolitinib
anti-PD-1
interferon alpha2b
title Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
title_full Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
title_fullStr Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
title_full_unstemmed Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
title_short Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
title_sort non melanoma skin cancer aggravation in polycythemia vera triggered by ruxolitinib and silenced with an ifn cemiplimab
topic cutaneous squamous cell carcinoma
Ruxolitinib
anti-PD-1
interferon alpha2b
url https://dpcj.org/index.php/dpc/article/view/4642
work_keys_str_mv AT efterpizafiriou nonmelanomaskincanceraggravationinpolycythemiaveratriggeredbyruxolitinibandsilencedwithanifncemiplimab
AT emmanouilkarampinis nonmelanomaskincanceraggravationinpolycythemiaveratriggeredbyruxolitinibandsilencedwithanifncemiplimab
AT vasileiospapadopoulos nonmelanomaskincanceraggravationinpolycythemiaveratriggeredbyruxolitinibandsilencedwithanifncemiplimab
AT georgiastefani nonmelanomaskincanceraggravationinpolycythemiaveratriggeredbyruxolitinibandsilencedwithanifncemiplimab
AT athanasioskotsakis nonmelanomaskincanceraggravationinpolycythemiaveratriggeredbyruxolitinibandsilencedwithanifncemiplimab
AT georgevassilopoulos nonmelanomaskincanceraggravationinpolycythemiaveratriggeredbyruxolitinibandsilencedwithanifncemiplimab